TB-402: Completed Phase II enrollment

The partners completed enrollment of 315 patients in an open-label, European Phase II trial comparing 0.3, 0.6 and 1.2 mg/kg IV TB-402 vs. Lovenox enoxaparin from sanofi-aventis Group (Euronext:SAN...